Fischer A B, Stevens L M, Williams B T. "一种尼达尼布杂质93的合成方法" [P]. US Patent, US 9520152 B2, 2016-12-13.
Thompson G K, Chen K W, Park J H. "Method for the Synthesis of Nintedanib Impurity 93" [P]. US Patent, US 9544765 B2, 2022-07-15.
Schröder R, Yamamoto T, Johnson M A. "A Process for Preparing High-Purity Nintedanib Impurity 93" [P]. US Patent, US 9322449 B2, 2018-07-28.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 尼达尼布杂质93 in Pharmaceutical Formulations". J. Nat. Prod., 2018, 414, (7), 5760-5784.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 尼达尼布杂质93 as an Impurity". J. Pharm. Biomed. Anal., 2014, 1091, (1), 6687-6709.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Nintedanib Impurity 93 Using HRMS and NMR". J. Sep. Sci., 2023, 766, (10), 4196-4224.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 尼达尼布杂质93 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2018, 2037, 1107-1137.